UiPath (NYSE:PATH) has launched agentic AI automation solutions focused on healthcare, targeting workflows such as medical records management and claims processing. The company is partnering with ...
UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...
UiPath Inc. shares were on track for their worst daily drop on record after the automation-software company’s latest earnings marked a twist on the industry’s well-established doldrums. Software ...
UiPath, Inc. (NYSE:PATH) reported its fourth-quarter financial results after the bell Wednesday. Here's a look at the highlights. The company reported quarterly earnings of 22 cents per share which ...
UiPath (NYSE:PATH) shares sank 15.85% to $9.96 on Thursday, hitting a record low after the company's fiscal 2026 revenue forecast fell short of expectations. The automation software provider expects ...
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
UiPath launches AI-based Medical Record Summarization tool, reducing processing time from 45 minutes to minutes. Powered by Google Cloud, the agent improves accuracy, saves 40 minutes per referral, ...
PATH heads into Q4 earnings with revenues seen rising 9.7%, but weak stock momentum and neutral earnings signals leave investors weighing a hold stance.
Zacks Investment Research on MSN
UiPath, Inc. (PATH) is attracting investor attention: Here is what you should know
UiPath (PATH) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results